Proenkephalin in Heart Failure.

Heart Fail Clin

Department of Cardiovascular Sciences, NIHR Biomedical Research Centre, University of Leicester, Glenfield Hospital, Groby Road, Leicester LE3 9QP, UK. Electronic address:

Published: January 2018

AI Article Synopsis

  • The opioid system plays a complex role in heart failure, potentially offering protection while also having counterproductive effects.
  • Recent research highlights that proenkephalin levels can independently predict mortality and rehospitalization rates in acute heart failure, alongside traditional risk factors.
  • The article discusses the significance of enkephalins and delta-opioid receptors in cardiac function and reviews studies linking proenkephalin levels to prognosis and renal function in heart failure patients.

Article Abstract

The opioid system is activated in heart failure, which may be cardioprotective but may also be counter-regulatory. Recently, systemic proenkephalin activation has been investigated in various conditions predicting mortality and kidney injury. In acute heart failure, proenkephalin independently predicts mortality and heart failure rehospitalization in addition to traditional risk markers. It also predicts worsening renal function, increasingly recognized as an important risk predictor for poor outcome in heart failure. This article explores the role of enkephalins and delta-opioid receptors in the heart, then reviews studies measuring proenkephalin levels in the circulation and their associations with prognosis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hfc.2017.08.001DOI Listing

Publication Analysis

Top Keywords

heart failure
20
failure
5
heart
5
proenkephalin
4
proenkephalin heart
4
failure opioid
4
opioid system
4
system activated
4
activated heart
4
failure cardioprotective
4

Similar Publications

Background: The impact of iron deficiency on COPD morbidity independent of anemia status is unknown. Understanding the association between iron deficiency, anemia status, and risk of hospitalization in COPD may inform an approach to these comorbidities.

Study Design And Methods: Adults ≥40 years from the Johns Hopkins COPD Precision Medicine Center of Excellence data repository with an outpatient iron profile and 1 year of subsequent follow-up time were included in the study.

View Article and Find Full Text PDF

chitinase-like protein orchestrates cyst wall glycosylation to facilitate effector export and cyst turnover.

Proc Natl Acad Sci U S A

February 2025

Department of Molecular Microbiology, Washington University in St. Louis, School of Medicine, St. Louis, MO 63130.

bradyzoites reside in tissue cysts that undergo cycles of expansion, rupture, and release to foster chronic infection. The glycosylated cyst wall acts as a protective barrier, although the processes responsible for formation, remodeling, and turnover are not understood. Herein, we identify a noncanonical chitinase-like enzyme TgCLP1 that localizes to micronemes and is targeted to the cyst wall after secretion.

View Article and Find Full Text PDF

Background: Myocardial ischemia-reperfusion injury (MIRI) is an important complication in the treatment of heart failure, and its treatment has not made satisfactory progress. Nitroxyl (HNO) showed protective effects on the heart failure, however, the effect and underlying mechanism of HNO on MIRI remain largely unclear.

Methods: MIRI model in this study was established to induce H9C2 cell injury through hypoxia/reoxygenation (H/R) in vitro.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!